S

Savara
D

SVRA

3.46000
USD
0.06
(1.76%)
مغلق
حجم التداول
42,368
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
593,801,546
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADAP
    -0.00320
    (-0.54%)
    0.58680 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    E
    EIGR
    0
    (0%)
    0.000000 USD
    J
    JNCE
    0.08500
    (5.31%)
    1.68000 USD
    K
    KRTX
    0
    (0%)
    0.000000 USD
    K
    KURA
    -0.560
    (-3.40%)
    15.920 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    V
    VSTM
    -0.13500
    (-3.26%)
    4.00000 USD
    المزيد
الأخبار

العنوان: Savara

القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.